Sintx Technologies, Inc. (SINT) Stock Price, Financials & Summary

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$1.70

From 52W high−60.09%

Volume22256.00

Market cap$12.85M

P/E (TTM)—

P/S (TTM)9.3x

Div yield—

Key dataOct 19, 2026

Open

$1.70

From 52W high

−60.09%

Volume

22256.00

Market cap

$12.85M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−1.2x

P/E (TTM)

—

RSI (14)

36.7

MomentumView details →

1D Return

−2.30%

YTD Return

−55.96%

SummaryUpdated Jun 1, 2026

Sintx Technologies, Inc. (NASDAQ:SINT) is an advanced materials company founded in 1996 and headquartered in Salt Lake City, Utah. Originally incorporated as Amedica Corporation before rebranding to its current name, the company has been publicly traded since 2014. Sintx specializes in the research, development, and commercialization of silicon nitride-based materials and medical devices, positioning itself at the intersection of advanced ceramics technology and biomedical applications.

Ask drillr about Sintx Technologies, Inc. →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−1.2x

EV/Sales

8.9x

P/S (TTM)

9.3x

P/B (TTM)

2.7x

ProfitabilityView details →

Gross Margin

−4.63%

Net Margin

−1303.40%

EBITDA Margin

−768.65%

ROE (TTM)

−372.67%

ROA (TTM)

−172.58%

Asset Turnover

0.15x

GrowthView details →

Revenue YoY

+0.22%

EPS YoY

+47.56%

FCF YoY

−35.57%

Revenue CAGR 3Y

+19.20%

EPS CAGR 3Y

+58.57%

EBITDA YoY

+8.44%

MomentumView details →

1D Return

−2.30%

YTD Return

−55.96%

1Y Return

−49.25%

RSI (14)

36.7

vs 50D SMA

−4.71%

vs 200D SMA

−26.89%

Capital & dividendView details →

Debt/Equity

0.63x

Current Ratio

2.36x

Quick Ratio

1.60x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.75

EPS Surprise

−2.74%

Beats (12Q)

4/12

Next Q EPS Est

−$0.34

Avg Surprise (4Q)

−145.77%

Rev Surprise

−1.74%

Financials snapshotView financials →

Revenue (TTM)

1.38M

Net Income (TTM)

−18.00M

Op. CF (TTM)

−10.12M

Next earningsNov 11, 2026 →

Latest newsMore news →

Sintx Technologies reported preliminary Q3 2026 revenue of $2.2 million, including $2.1 million in product sales, up roughly 380% quarter-over-quarter and over 10x year-over-year.18d ago

SINTX Technologies announced the availability of a company-sponsored Masterclass hosted by Orthopedics This Week featuring three industry experts discussing the value of silicon nitride versus legacy implant materials in orthopedic applications.35d ago

Similar companies

IRIDEX CorporationIRIX Baird Medical Investment Holdings LimitedBDMD Pulsenmore Ltd. Ordinary SharesPLSM HeartSciences Inc.HSCS Cytosorbents CorporationCTSO Lifeward Ltd.LFWD Find similar companies →

Latest newsMore news →

Sintx Technologies reported preliminary Q3 2026 revenue of $2.2 million, including $2.1 million in product sales, up roughly 380% quarter-over-quarter and over 10x year-over-year.18d ago SINTX Technologies announced the availability of a company-sponsored Masterclass hosted by Orthopedics This Week featuring three industry experts discussing the value of silicon nitride versus legacy implant materials in orthopedic applications.35d ago